Organization Overview
Historical Acquisition Tree
Alternative names
satumomab pendetide (Oncoscint) (1992 NDA)
Breast Neoplasms (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms, Second Primary (Phase 2)
Prostatic Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)